Sterling Financial Planning’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-100
Closed -$4K 433
2021
Q2
$4K Hold
100
﹤0.01% 367
2021
Q1
$3K Buy
+100
New +$3K ﹤0.01% 353